Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Matteucci

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Molecular Imaging and Biology|November 24, 2019
SUV<sub>95th</sub> as a Reliable Alternative to SUV<sub>max</sub> for Determining Renal Uptake in [<sup>68</sup>Ga] PSMA PET/CTSerena Baiocco, Federica Matteucci, Emilio Mezzenga, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2013
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumoursStefano Severi, Oriana Nanni, Lisa Bodei, et al.
Scientific Reports|May 8, 2021
Spotlight on PSMA as a new theranostic biomarker for bladder cancerMaria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 9, 2016
IntegoTM infusion system: cost effectiveness analysis focusing on dosimetry, sterility and managementFederica Matteucci, Laura Solinas, Valentina Turri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2014
177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II studyGiovanni Paganelli, Maddalena Sansovini, Alice Ambrosetti, et al.
American Journal of Hematology|October 19, 2010
Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G)Gerardo Musuraca, Pier Paolo Fattori, Michela Ceccolini, et al.
Cancers|April 23, 2022
Radiomics Analysis on [<sup>68</sup>Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE TrialGiacomo Feliciani, Monica Celli, Fabio Ferroni, et al.
Current Medical Imaging|September 17, 2021
[<sup>18</sup>F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic ReviewPriscilla Guglielmo, Natale Quartuccio, Virginia Rossetti, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Production and Quality Control of [<sup>68</sup>Ga]Ga-FAPI-46: Development of an Investigational Medicinal Product Dossier for a Bicentric Clinical TrialAlessandro Cafaro, Cristina Cuni, Stefano Boschi, et al.
Cancer Treatment and Research Communications|March 14, 2026
PSMA for HCC: a new frontier in precision medicine for liver cancer?Paola Caroli, Virginia Rossetti, Maddalena Sansovini, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Molecular Imaging and Biology|November 24, 2019
SUV<sub>95th</sub> as a Reliable Alternative to SUV<sub>max</sub> for Determining Renal Uptake in [<sup>68</sup>Ga] PSMA PET/CTSerena Baiocco, Federica Matteucci, Emilio Mezzenga, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2013
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumoursStefano Severi, Oriana Nanni, Lisa Bodei, et al.
Scientific Reports|May 8, 2021
Spotlight on PSMA as a new theranostic biomarker for bladder cancerMaria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 9, 2016
IntegoTM infusion system: cost effectiveness analysis focusing on dosimetry, sterility and managementFederica Matteucci, Laura Solinas, Valentina Turri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2014
177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II studyGiovanni Paganelli, Maddalena Sansovini, Alice Ambrosetti, et al.
American Journal of Hematology|October 19, 2010
Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G)Gerardo Musuraca, Pier Paolo Fattori, Michela Ceccolini, et al.
Cancers|April 23, 2022
Radiomics Analysis on [<sup>68</sup>Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE TrialGiacomo Feliciani, Monica Celli, Fabio Ferroni, et al.
Current Medical Imaging|September 17, 2021
[<sup>18</sup>F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic ReviewPriscilla Guglielmo, Natale Quartuccio, Virginia Rossetti, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Production and Quality Control of [<sup>68</sup>Ga]Ga-FAPI-46: Development of an Investigational Medicinal Product Dossier for a Bicentric Clinical TrialAlessandro Cafaro, Cristina Cuni, Stefano Boschi, et al.
Cancer Treatment and Research Communications|March 14, 2026
PSMA for HCC: a new frontier in precision medicine for liver cancer?Paola Caroli, Virginia Rossetti, Maddalena Sansovini, et al.
Pageof 8